This inventor holds 3 USPTO granted patents. Top assignee: Funzyme Biotechnologies Sa. Active years: 2008-2011.
Company Filing History:
Years Active: 2008-2011
Title: Reto Stocklin: Innovator in Fungal Biotechnology
Introduction
Reto Stocklin is a notable inventor based in Plan-les-Ouates, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of fungal enzymes. With a total of three patents to his name, Stocklin's work has implications for various medical and commercial applications.
Latest Patents
Stocklin's latest patents include the development of a fungal dipeptidyl peptidase IV (DPPIV) enzyme for reagent use. This patent discloses fungal nucleic acid sequences that encode novel DPPIV polypeptides. It also details the polypeptides encoded by these sequences, including derivatives, variants, mutants, or fragments. The DPPIV proteins are useful in a variety of medical, research, and commercial applications. Another significant patent involves fungal proteins and nucleic acids encoding novel polypeptides. This patent also describes leucine aminopeptidase (LAP) and other amino- and carboxypeptidases, which have various applications in the same fields.
Career Highlights
Reto Stocklin is currently associated with Funzyme Biotechnologies SA, where he continues to innovate in the field of biotechnology. His work focuses on harnessing the potential of fungal enzymes for practical applications.
Collaborations
Stocklin collaborates with notable colleagues, including Michel Monod and Eric Grouzmann, who contribute to his research and development efforts.
Conclusion
Reto Stocklin's contributions to fungal biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical and commercial applications.